Literature DB >> 33704879

Long non-coding RNA ADAMTS9-AS1 inhibits the progression of prostate cancer by modulating the miR-142-5p/CCND1 axis.

Zhien Zhou1, Xingcheng Wu1, Yi Zhou1, Weigang Yan1.   

Abstract

BACKGROUND: Emerging evidence has implied the importance of long non-coding RNAs in cancer development, including prostate cancer (PCa). Bioinformatic analyses have identified that ADAMTS9-AS1 may play a role in cancer progression.
METHODS: A quantitative real-time polymerase chain reaction was conducted to measure ADAMTS9-AS1 expression level at messenger RNA level. In vitro functional analyses were performed to investigate cell behaviors status under different conditions. Moreover, rescue assays were conducted to explore the potential mechanisms of ADAMTS9-AS1 in PCa progression.
RESULTS: ADAMTS9-AS1 expression is down-regulated in PCa. Forcing ADAMTS9-AS1 expression impedes PCa cell proliferation via initiating cell apoptosis. Importantly, microRNA-142-5p (miR-142-5p) mimic and small-interfering RNA targeting cyclin D1 (CCND1, si-CCND1) could attenuate the inhibitory effects of ADAMTS9-AS1 overexpression on PCa cell growth.
CONCLUSIONS: Collectively, our results indicate that ADAMTS9-AS1 suppresses PCa progression by regulating the miR-142-5p/CCND1 axis, which provides a new mechanism for the progression of PCa.
© 2021 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ADAMTS9-AS1; CCND1; long non-coding RNA; miR-142-5p; prostate cancer

Mesh:

Substances:

Year:  2021        PMID: 33704879     DOI: 10.1002/jgm.3331

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  6 in total

1.  RASAL2 regulates the cell cycle and cyclin D1 expression through PI3K/AKT signalling in prostate tumorigenesis.

Authors:  Qi Wang; Shiqi Wu; Yanan Gu; Hua Liang; Fei He; Xinyang Wang; Dalin He; Kaijie Wu
Journal:  Cell Death Discov       Date:  2022-06-06

2.  Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer.

Authors:  Li Cai; Xiaoqing Hu; Lu Ye; Pingjuan Bai; Youkun Jie; Kuanyong Shu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  ADAMTS9-AS1 Constrains Breast Cancer Cell Invasion and Proliferation via Sequestering miR-301b-3p.

Authors:  Junqing Chen; Ling Cheng; Weibin Zou; Rong Wang; Xiaojia Wang; Zhanhong Chen
Journal:  Front Cell Dev Biol       Date:  2021-11-24

4.  lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing Hypertrophic Cardiomyopathy.

Authors:  Wei Feng; Shuo Han
Journal:  Oxid Med Cell Longev       Date:  2022-03-31       Impact factor: 6.543

5.  A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma.

Authors:  Xiaobo Shi; Xiaoxiao Liu; Shupei Pan; Yue Ke; Yuxing Li; Wei Guo; Yuchen Wang; Qinli Ruan; Xiaozhi Zhang; Hongbing Ma
Journal:  Int J Gen Med       Date:  2021-11-16

6.  LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.

Authors:  Xiaowei Cai; Yiheng Dai; Peng Gao; Guanyu Ren; Dingcai Cheng; Bo Wang; Yi Wang; Jiang Yu; Yiheng Du; Xizhi Wang; Boxin Xue
Journal:  Aging (Albany NY)       Date:  2021-07-28       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.